Next Milestone Ventures

drew1

Colonai

Technologies

Medical Device

Indication

Autoimmune & Inflammation

Central Nervous System Disorders

Disease Surveillance

Metabolic Disease

Obesity

Oncology

Additional Information

Women Owned

Drew Afromsky

Colonai develops artificial intelligence-enabled software guidance systems to improve colorectal cancer screening by preventing two key problems during colonoscopy: missed tumors and incompletely removed tumors.

 

2020 PITCH DAY VIDEO

Newsletter Signup

Corporate Supporter


wbca-dashed-rule

Westchester County Biosciences Accelerator is a Program of

Initiated by